Mostrar el registro sencillo del ítem

dc.contributor.authorNguyen, L T T
dc.contributor.authorRoman, Federico 
dc.contributor.authorMorikawa, K
dc.contributor.authorTrincado, Pilar 
dc.contributor.authorMarcos-Moreno, Maria del Carmen 
dc.contributor.authorRojo-Martín, M D
dc.contributor.authorCafini, F
dc.date.accessioned2020-06-02T10:25:25Z
dc.date.available2020-06-02T10:25:25Z
dc.date.issued2018
dc.identifier.citationInt J Antimicrob Agents. 2018 Aug;52(2):305-306es_ES
dc.identifier.issn0924-8579es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10254
dc.description.abstractAs a consequence of the dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strains and the accumulation of several resistant traits, only a few antibiotics such as vancomycin or linezolid are considered as the last resort antibiotics for the treatment of these strains. The finding of a transferable chloramphenicol/florphenicol resistance (cfr) gene, related to linezolid resistance, has compromised the usage of this antimicrobial in the clinical practice. Although the prevalence of MRSA strains showing resistance to linezolid is still low, hospital outbreaks due to cfr-positive MRSA strains have been documented in Spain [1].es_ES
dc.description.sponsorshipTravel grant was supported by Human Biology Program, School of Integrative and Global Majors, University of Tsukuba (LTTNes_ES
dc.language.isoenges_ES
dc.publisherElsevier es_ES
dc.type.hasVersionAMes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshChloramphenicol Resistance es_ES
dc.subject.meshGenetic Vectors es_ES
dc.subject.meshHumans es_ES
dc.subject.meshPlasmids es_ES
dc.subject.meshPrevalence es_ES
dc.subject.meshSpain es_ES
dc.subject.meshStaphylococcal Infections es_ES
dc.subject.meshStaphylococcus es_ES
dc.titlePrevalence of pSCFS7-like vectors among cfr-positive staphylococcal population in Spaines_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID29898410es_ES
dc.format.volume52es_ES
dc.format.number2es_ES
dc.format.page305-306es_ES
dc.identifier.doi10.1016/j.ijantimicag.2018.06.004es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1872-7913es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.ijantimicag.2018.06.004es_ES
dc.identifier.journalInternational journal of antimicrobial agentses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional